Literature DB >> 11604399

A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.

D A Wang1, Z Lorincz, D L Bautista, K Liliom, G Tigyi, A L Parrill.   

Abstract

The phospholipid growth factors sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) are ligands for the related G protein-coupled receptors S1P(1)/EDG1 and LPA(1)/EDG2, respectively. We have developed a model of LPA(1) that predicts interactions between three polar residues and LPA. One of these, glutamine 125, which is conserved in the LPA receptor subfamily (LPA(1)/EDG2, LPA(2)/EDG4, and LPA(3)/EDG7), hydrogen bonds with the LPA hydroxyl group. Our previous S1P(1) study identified that the corresponding glutamate residue, conserved in all S1P receptors, ion pairs with the S1P ammonium. These two results predict that this residue might influence ligand recognition and specificity. Characterization of glutamate/glutamine interchange point mutants of S1P(1) and LPA(1) validated this prediction as the presence of glutamate was required for S1P recognition, whereas LPA recognition was possible with either glutamine or glutamate. The most likely explanation for this dual specificity behavior is a shift in the equilibrium between the acid and conjugate base forms of glutamic acid due to other amino acids surrounding that position in LPA(1), producing a mixture of receptors including those having an anionic glutamate that recognize S1P and others with a neutral glutamic acid that recognize LPA. Thus, computational modeling of these receptors provided valid information necessary for understanding the molecular pharmacology of these receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604399     DOI: 10.1074/jbc.M107301200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 2.  Regulation of immunity by lysosphingolipids and their G protein-coupled receptors.

Authors:  Edward J Goetzl; Hugh Rosen
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.

Authors:  Yuko Fujiwara; Daniel A Osborne; Michelle D Walker; De-an Wang; Debra A Bautista; Karoly Liliom; James R Van Brocklyn; Abby L Parrill; Gabor Tigyi
Journal:  J Biol Chem       Date:  2006-11-18       Impact factor: 5.157

4.  Molecular recognition in the sphingosine 1-phosphate receptor family.

Authors:  Truc-Chi T Pham; James I Fells; Daniel A Osborne; E Jeffrey North; Mor M Naor; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2007-11-17       Impact factor: 2.518

5.  Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling.

Authors:  Chananat Klomsiri; LeAnn C Rogers; Laura Soito; Anita K McCauley; S Bruce King; Kimberly J Nelson; Leslie B Poole; Larry W Daniel
Journal:  Free Radic Biol Med       Date:  2014-03-21       Impact factor: 7.376

6.  Crystal structure of a lipid G protein-coupled receptor.

Authors:  Michael A Hanson; Christopher B Roth; Euijung Jo; Mark T Griffith; Fiona L Scott; Greg Reinhart; Hans Desale; Bryan Clemons; Stuart M Cahalan; Stephan C Schuerer; M Germana Sanna; Gye Won Han; Peter Kuhn; Hugh Rosen; Raymond C Stevens
Journal:  Science       Date:  2012-02-17       Impact factor: 47.728

7.  Role of the G-protein-coupled receptor GPR12 as high-affinity receptor for sphingosylphosphorylcholine and its expression and function in brain development.

Authors:  Atanas Ignatov; Julia Lintzel; Irm Hermans-Borgmeyer; Hans-Jürgen Kreienkamp; Patrick Joost; Susanne Thomsen; Axel Methner; H Chica Schaller
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

8.  Lack of stereospecificity in lysophosphatidic acid enantiomer-induced calcium mobilization in human erythroleukemia cells.

Authors:  Ulrika K Nilsson; Rolf G G Andersson; Johan Ekeroth; Elisabeth C Hallin; Peter Konradsson; Jan Lindberg; Samuel P S Svensson
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

9.  The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury.

Authors:  Wenlin Deng; E Shuyu; Ryoko Tsukahara; William J Valentine; Gangadhar Durgam; Veeresa Gududuru; Louisa Balazs; Venkatraman Manickam; Marcello Arsura; Lester VanMiddlesworth; Leonard R Johnson; Abby L Parrill; Duane D Miller; Gabor Tigyi
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

10.  Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.

Authors:  Gyöngyi N Kiss; James I Fells; Renuka Gupte; Sue-Chin Lee; Jianxiong Liu; Nóra Nusser; Keng G Lim; Ramesh M Ray; Fang-Tsyr Lin; Abby L Parrill; Balázs Sümegi; Duane D Miller; Gabor Tigyi
Journal:  Mol Pharmacol       Date:  2012-09-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.